Javascript must be enabled to continue!
Everolimus‐induced gastric antral vascular ectasia in advanced renal cancer
View through CrossRef
IntroductionAlthough several medical, endoscopic, and surgical treatment options are available, the management of gastric antral vascular ectasia remains clinically challenging. We report a case of gastric antral vascular ectasia due to everolimus use in a patient with advanced renal cancer.Case presentationA 71‐year‐old man was diagnosed with right‐sided renal cancer and multiple lung metastases. In the period of everolimus as third‐line therapy, endoscopy of the upper gastrointestinal tract revealed everolimus‐induced gastric antral vascular ectasia. Endoscopic argon plasma coagulation and variceal ligation were repeated seven times within a month of everolimus cessation. Subsequently, an antrectomy was performed; his postoperative course was uneventful.ConclusionBased on our experience, we believe that an antrectomy is important in the management of mammalian target of rapamycin inhibitor‐related gastric antral vascular ectasia.
Title: Everolimus‐induced gastric antral vascular ectasia in advanced renal cancer
Description:
IntroductionAlthough several medical, endoscopic, and surgical treatment options are available, the management of gastric antral vascular ectasia remains clinically challenging.
We report a case of gastric antral vascular ectasia due to everolimus use in a patient with advanced renal cancer.
Case presentationA 71‐year‐old man was diagnosed with right‐sided renal cancer and multiple lung metastases.
In the period of everolimus as third‐line therapy, endoscopy of the upper gastrointestinal tract revealed everolimus‐induced gastric antral vascular ectasia.
Endoscopic argon plasma coagulation and variceal ligation were repeated seven times within a month of everolimus cessation.
Subsequently, an antrectomy was performed; his postoperative course was uneventful.
ConclusionBased on our experience, we believe that an antrectomy is important in the management of mammalian target of rapamycin inhibitor‐related gastric antral vascular ectasia.
Related Results
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract
Introduction
Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Risk factors for ectasia after laser in situ keratomileusis in an Egyptian population sample
Risk factors for ectasia after laser in situ keratomileusis in an Egyptian population sample
Purpose
The aim of this study was to determine the prevalence and risk factors of post-laser in situ keratomileusis (post-LASIK) ectasia in an Egyptian population sampl...
Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins
Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins
Drug-eluting stents, which release antiproliferative agents such as sirolimus and everolimus, were developed to reduce the risk of restenosis associated with bare-metal stents. How...
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
Multi-dimensional cell-free DNA-based liquid biopsy and early detection of gastric cancer.
4060 Background: Gastric cancer is one of the most common cancer types. Most patients were diagnosed at advanced stages and experienced poor prognosis. A non-invasive assay for th...
Overall survival with everolimus, sunitinib, and placebo for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison of randomized trials.
Overall survival with everolimus, sunitinib, and placebo for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison of randomized trials.
237 Background: Everolimus and sunitinib are approved in the US and EU for treating advanced pancreatic neuroendocrine tumors (pNET). No randomized trial has directly compared the...
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study
AbstractIntroduction.The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are ...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Abstract 3055: Xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, shows efficacy in a human breast cancer model of bone metastasis
Abstract 3055: Xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, shows efficacy in a human breast cancer model of bone metastasis
Abstract
Bone metastases are a frequent complication of cancer and are associated with considerable morbidity. Bones provide a permissive environment for metastatic ...

